Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Org 24448 for Cognitive Impairment in Schizophrenia
NCT00425815Phase 2Withdrawn
- Sponsor
- University of California, Los Angeles
- Start
- Apr 2009
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of farampator in schizophrenia, sponsored by University of California, Los Angeles. Planned start Apr 2009; status: withdrawn.
02
Drugs
farampator
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00425815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425815.